Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06066333
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- ACC
- Adrenocortical Carcinoma
- Metastatic Adrenocortical Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ablative Radiotherapy — RADIATIONAll participants will first undergo ablative RT
- Pembrolizumab — DRUGAfter completion of ablative RT, all subjects may begin pembrolizumab treatment
Study Details
The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortical Carcinoma.
Key Dates
- Start date
- Sep 27, 2023
- Status verified
- Apr 2026
- Primary completion
- Sep 27, 2026
- Completion
- Sep 27, 2026
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Participants with Adrenocortical CarcinomaParticipants with histologically proven metastatic Adrenocortical Carcinoma/ACC with both intra-hepatic and extra-hepatic sites of disease.
Primary Outcome Measure
Number of participants evaluated for AEs [ Time Frame: up to 1 year ]
Central Contacts
- Nitya Raj, MD646-888-4849
- Rohit Thummalapalli, MD646-888-4494
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | New Jersey | 07920 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | New Jersey | 07748 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | New Jersey | 07645 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Suffolk-Commack | Commack | New York | 11725 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | New York | 10604 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Nitya Raj, MD 646-888-4849 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | New York | 11553 | Nitya Raj, MD 646-888-4849 |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk-Commack· Commack, NYMemorial Sloan Kettering Westchester (All Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- Familial Investigations of Childhood Cancer PredispositionRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsPHASE1 · Recruiting · Anusha Kalbasi · Duarte, California